Migraine is a prevalent neurological disorder characterized by recurrent, debilitating headaches that can significantly impact a person's quality of life.

In the realm of migraine management, the array of FDA-approved drugs highlights a timeline of therapeutic evolution and innovation.

To enhance patient outcomes in migraine clinical trials, it is necessary to focus not only on the physiological aspects of migraine relief but also on overall improvements in the quality of life. Endpoints must therefore be relevant to daily living and long-term health.

iNGENū’s team of researchers and clinicians is dedicated to advancing migraine research. Through innovative trial designs and a patient-centered approach, we work to accelerate the development of new treatments that could offer improved options and outcomes for those affected by migraine.